News

CH3 product most popular at tebu-bio!

Posted on January 19, 2014September 14, 2017 by John Aletta

19
Jan

Discover the most popular product on our website this week! https://t.co/A0AFg1Fhmr @CH3Bio #adenocarcinoma cell line
— tebu-bio (@tebubio) January 17, 2014

John Aletta

John M. Aletta is a Co-Founder and the Director of Research at CH3 BioSystems. In 1997, his laboratory was the first to demonstrate a requirement for specific protein methylation in the cellular development of neuronal model systems.

Leave a Reply Cancel reply